ME Therapeutics Holdings Inc. Stock
Stocks
METX
CA5527671054
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
04:03:56 15/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.600 CAD | -28.89% |
|
-36.00% | -60.00% |
| 09/09 | Me Therapeutics Holdings Advances in Vivo Car and Therapeutic Mrna Sting Programs | CI |
| 18/07 | ME Therapeutics Holdings Inc. announced that it has received CAD 0.576501 million in funding | CI |
| Market Cap | 75.97M 54.62M 47.33M 44.66M 40.49M 5.22B 76.57M 533M 205M 2.66B 205M 201M 8.44B | P/E 2024 |
-51.7x | P/E 2025 | -93.2x |
|---|---|---|---|---|---|
| Enterprise Value | 74.64M 53.67M 46.5M 43.88M 39.78M 5.13B 75.23M 524M 201M 2.61B 202M 197M 8.29B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
44.63% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| METX | Delayed | |
OTC Markets
| METXF | Delayed | |
|
Deutsche Boerse AG
| Q9T | Delayed |
| 1 day | -28.89% | ||
| 1 week | -36.00% | ||
| Current month | -36.00% | ||
| 1 month | -36.00% | ||
| 3 months | -19.60% | ||
| 6 months | -36.00% | ||
| Current year | -60.00% |
| 1 week | 1.6 |  | 2.25 |
| 1 month | 1.5 | | 3.25 |
| Current year | 0.79 | | 3.8 |
| 1 year | 0.79 | | 8 |
| 3 years | 0.05 | | 11 |
| 5 years | 0.05 | | 11 |
| 10 years | 0.05 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 46 | 09/03/2023 |
Quinn Martin
DFI | Director of Finance/CFO | 44 | 09/03/2023 |
Karim Lalji
PRN | Corporate Officer/Principal | - | 25/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Priatel
BRD | Director/Board Member | 60 | 09/03/2023 |
Salim Dhanji
BRD | Director/Board Member | 46 | 09/03/2023 |
Kenneth Harder
BRD | Director/Board Member | 59 | 09/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/7/26 | Option | Director | 294,118 | 0.9788% | ||
| 16/7/26 | Sell | Director | 294,118 | 0.9788% | ||
| 16/7/26 | Option | Chief Financial Officer | 125,000 | 0.4160% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.89% | -36.00% | -62.79% | - | 49.29M | |
| +0.56% | -5.82% | -2.45% | +9.99% | 45.48B | |
| +0.66% | -2.34% | +340.62% | +524.38% | 43.68B | |
| +1.49% | -0.78% | +41.90% | +22.65% | 43.09B | |
| +2.11% | -1.24% | +9.09% | +76.85% | 39.4B | |
| +0.34% | -4.94% | +9.34% | +40.23% | 31.91B | |
| +0.53% | -2.08% | - | - | 17.31B | |
| +1.34% | +0.70% | +21.35% | +111.39% | 16.4B | |
| +2.07% | -0.77% | +13.07% | +32.89% | 14.24B | |
| -1.85% | -5.33% | +78.63% | +34.13% | 13.28B | |
| Average | -2.16% | -3.68% | +49.86% | +106.56% | 26.48B | |
| Weighted average by Cap. | +0.93% | -3.26% | +75.97% | +126.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.29M -931K -807K -761K -690K -88.96M -1.3M -9.08M -3.49M -45.3M -3.5M -3.42M -144M | -1.19M -858K -743K -701K -636K -81.99M -1.2M -8.37M -3.22M -41.75M -3.22M -3.15M -133M |
| Net Debt | -1.5M -1.08M -932K -880K -798K -103M -1.51M -10.5M -4.04M -52.38M -4.04M -3.96M -166M | -1.33M -957K -829K -783K -709K -91.48M -1.34M -9.34M -3.59M -46.58M -3.6M -3.52M -148M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | CAD 1.600 | -28.89% | 1,100 |
- Stock Market
- Stocks
- METX Stock
Select your edition
All financial news and data tailored to specific country editions
